Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Debt / NOTE 0.500% 8/1
-
Market price (% of par)
-
94.12%
-
Total 13F principal
-
$538,206,300
-
Principal change
-
-$28,373,369
-
Total reported market value
-
$508,477,282
-
Number of holders
-
66
-
Value change
-
-$36,380,490
-
Number of buys
-
26
-
Number of sells
-
23
Institutional Holders of INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 as of Q2 2022
As of 30 Jun 2022,
INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 was held by
66 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$538,206,300
in principal (par value) of the bond.
The largest 10 bondholders included
Invesco Ltd., HIGHBRIDGE CAPITAL MANAGEMENT LLC, CALAMOS ADVISORS LLC, MACKAY SHIELDS LLC, Aequim Alternative Investments LP, CITIGROUP INC, AVIVA PLC, Shaolin Capital Management LLC, JPMORGAN CHASE & CO, and SHENKMAN CAPITAL MANAGEMENT INC.
This page lists
66
institutional bondholders reporting positions
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.